<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Encounter Summary</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Encounter Summary</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">Sooil Kim</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">April 4, 1945 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Male</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Unknown</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Unknown</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>unk</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Primary Home Address:<br/>150 S COMMONWEALTH AVE<br/>LOS ANGELES, CA 90004, USA<br/>Effective Date: August 10, 2021 <br/><br/> Previous Address:<br/><br/>, USA<br/>Effective Date: August 10, 2021 <br/>Expiration Date: August 9, 2021 <br/><br/>Primary Home Phone:  +1-213-382-6381<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">CSH6BJ58RZW47XT 1.2.840.114350.1.13.202.2.7.3.688884.100<br/>8GC6Q97KK78 1.2.840.114350.1.13.202.2.7.5.698077.480050<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value"> 1.2.840.114350.1.13.202.2.7.8.688883.818507773</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">January 14, 2025, 10:48:04, PST </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Pagiel Shechter,  MD of Cedars-Sinai Health System</td></tr><tr><td class="td_header_role_value internal_format"><br/><br/>Work Phone:  +1-310-733-4171<br/>Fax:  +1-310-559-0996<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">Epic - Version 10.9</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">29224627150 1.2.840.114350.1.13.202.2.7.3.698084.8</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">Office Visit</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From May 24, 2023, 15:00:00, MST  to May 24, 2023, 15:20:00, MST </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value">Nilly Shechter, M.D., Pagiel Shechter, M.D. of </td></tr><tr><td class="td_header_role_name"><span class="td_label">Responsible party</span></td><td class="td_header_role_value">Pagiel Shechter of Cedars-Sinai Health System</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Work Address:<br/>6222 WILSHIRE BLVD<br/>SUITE 304<br/>LOS ANGELES, CA 90048, USA<br/><br/>Work Phone:  +1-310-733-4171<br/>Fax:  +1-310-559-0996<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Legal authenticator</span></td><td class="td_header_role_value">Health Information Executive Director CSHS signed at January 14, 2025, 10:48:04, PST </td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">Cedars-Sinai Health System</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Work Address:<br/>8700 Beverly Blvd.<br/>Los Angeles, CA 90048, USA<br/><br/>Work Phone:  +1-310-423-2259<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Reason for Visit</a></li><li><a href="#id2">Encounter Details</a></li><li><a href="#id3">Social History</a></li><li><a href="#id4">Last Filed Vital Signs</a></li><li><a href="#id5">Progress Notes</a></li><li><a href="#id6">Plan of Treatment</a></li><li><a href="#id7">Visit Diagnoses</a></li><li><a href="#id8">Care Teams</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Reason for Visit</a></h3><div><ul><li><table><colgroup><col width="25%"/><col width="75%"/></colgroup><thead><tr><th>Reason</th><th>Comments</th></tr></thead><tbody><tr ID="rfv2"><td ID="reasonrfv2">Follow-up</td><td/></tr></tbody></table></li></ul></div><h3><a name="id2" href="#toc">Encounter Details</a></h3><div><table><colgroup><col width="10%"/><col width="15%"/><col width="25%" span="3"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter3" class="xRowNormal"><td>05/24/2023  3:00 PM PDT</td><td ID="encounter3type">Office Visit</td><td><p>Nilly Shechter, M.D., Pagiel Shechter, M.D.</p><p>6222 WILSHIRE BLVD STE 304</p><p>LOS ANGELES, CA 90048</p><p>310-733-4171</p></td><td><p>Shechter, Pagiel, MD</p><p>6222 WILSHIRE BLVD</p><p>SUITE 304</p><p>LOS ANGELES, CA 90048</p><p>310-733-4171 (Work)</p><p>310-559-0996 (Fax)</p></td><td><content>Chronic kidney disease (CKD) stage G3b/A1, moderately decreased glomerular filtration rate (GFR) between 30-44 mL/min/1.73 square meter and albuminuria creatinine ratio less than 30 mg/g (HCC) (Primary Dx); <br/>Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin (HCC)</content></td></tr></tbody></table></div><h3><a name="id3" href="#toc">Social History</a></h3><div><table ID="sochist8"><colgroup><col width="25%" span="2"/><col width="13%"/><col width="12%"/><col width="25%"/></colgroup><thead><tr><th>Tobacco Use</th><th>Types</th><th>Packs/Day</th><th>Years Used</th><th>Date</th></tr></thead><tbody><tr><td>Smoking Tobacco: Never Assessed</td><td/><td ID="sochist8packsperday"/><td/><td/></tr></tbody></table><table><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Sex and Gender Information</th><th>Value</th><th>Date Recorded</th></tr></thead><tbody><tr ID="BirthSex11"><td>Sex Assigned at Birth</td><td ID="BirthSex11Value">Not on file</td><td/></tr><tr ID="LegalSex12"><td>Legal Sex</td><td ID="LegalSex12Value">Male</td><td>08/10/2021 12:00 PM PDT</td></tr><tr ID="GenderIdentity9"><td>Gender Identity</td><td ID="GenderIdentity9Value">Not on file</td><td/></tr><tr ID="SexualOrientation10"><td>Sexual Orientation</td><td ID="SexualOrientation10Value">Not on file</td><td/></tr></tbody></table>documented as of this encounter</div><h3><a name="id4" href="#toc">Last Filed Vital Signs</a></h3><div><table><colgroup><col width="25%" span="4"/></colgroup><thead><tr><th>Vital Sign</th><th>Reading</th><th>Time Taken</th><th>Comments</th></tr></thead><tbody><tr class="xRowNormal"><td class="xcellHeader">Blood Pressure</td><td><span class="content_span">124</span>/<span class="content_span">78</span></td><td>05/24/2023 10:09 AM PDT</td><td/></tr><tr ID="pulse_5755856940" class="xRowAlt"><td class="xcellHeader">Pulse</td><td>65</td><td>05/24/2023 10:09 AM PDT</td><td/></tr><tr ID="temp_5755856940" class="xRowNormal"><td class="xcellHeader">Temperature</td><td>36.2 °C (97.1 °F)</td><td>05/24/2023 10:09 AM PDT</td><td/></tr><tr ID="resp_5755856940" class="xRowAlt"><td class="xcellHeader">Respiratory Rate</td><td>17</td><td>05/24/2023 10:09 AM PDT</td><td/></tr><tr ID="SpO2_5755856940" class="xRowNormal"><td class="xcellHeader">Oxygen Saturation</td><td>98%</td><td>05/24/2023 10:09 AM PDT</td><td/></tr><tr ID="inhaled_" class="xRowAlt"><td class="xcellHeader">Inhaled Oxygen Concentration</td><td>-</td><td>-</td><td/></tr><tr ID="weight_5755856940" class="xRowNormal"><td class="xcellHeader">Weight</td><td>71.7 kg (158 lb)</td><td>05/24/2023 10:09 AM PDT</td><td/></tr><tr ID="height_5755856940" class="xRowAlt"><td class="xcellHeader">Height</td><td>175.3 cm (5' 9")</td><td>05/24/2023 10:09 AM PDT</td><td/></tr><tr ID="bmi_5755856940" class="xRowNormal"><td class="xcellHeader">Body Mass Index</td><td>23.33</td><td>05/24/2023 10:09 AM PDT</td><td/></tr></tbody></table>documented in this encounter</div><h3><a name="id5" href="#toc">Progress Notes</a></h3><div><ul><li>Shechter, Pagiel, MD - 05/24/2023  3:00 PM PDT: <content><content><span class="xLabel">Formatting of this note is different from the original.</span><br/><span class="xLabel">Images from the original note were not included.</span><br/><br/> Pagiel Shechter, M.D.<br/>Internal Medicine &amp; Nephrology<br/>Assistant Clinical Professor, UCLA<br/><br/>6222 Wilshire Blvd., Suite 304<br/>Los Angeles, CA 90048<br/>Phone: (310) 733-4171<br/>Fax: (310) 559-0996<br/>Contact@pagielshecter.com<br/>www.pagielshechter.com <br/><br/>Office Progress Note<br/><br/>Date of Service: 5/24/2023 <br/>78 year old male<br/><br/>Subjective/ Interval Events: <br/>Events: None<br/>Complaints: None<br/>Active Treatments/Procedures: None<br/>Medications: <br/>Current Outpatient Medications <br/>Medication Sig <br/>• ranolazine (RANEXA) 500 mg ER tablet 12 hr  <br/>• traMADol (ULTRAM) 50 mg tablet  <br/>• ursodiol (URSO-FORTE) 500 mg tablet  <br/>• isosorbide mononitrate (IMDUR) 120 mg SR tablet 24 hr  <br/>• METOprolol succinate (TOPROL XL) 50 mg SR tablet 24 hr  <br/>• Praluent Pen 150 mg/mL subcutaneous pen injection  <br/>• albuterol (VENTOLIN HFA) 90 mcg/actuation HFA inhaler  <br/>• ALPRAZolam (XANAX) 1 mg tablet  <br/>• amLODIPine (NORVASC) 5 mg tablet  <br/>• atorvastatin (LIPITOR) 80 mg tablet  <br/>• bisacodyl (DULCOLAX) 5 mg EC DR tablet  <br/>• carbidopa-levodopa (SINEMET CR) 25-100 mg SR tablet  <br/>• cholecalciferol (VITAMIN D3) 125 mcg (5,000 unit) capsule  <br/>• clopidogrel (PLAVIX) 75 mg tablet  <br/>• dilTIAZem (CARDIZEM CD-once a day dosage) 180 mg SR capsule 24 hr  <br/>• entacapone (COMTAN) 200 mg tablet  <br/>• flecainide (TAMBOCOR) 50 mg tablet  <br/>• Procto-Med HC 2.5 % rectal cream  <br/>• isosorbide mononitrate (IMDUR) 60 mg SR tablet 24 hr  <br/>• lactulose 10gm/15ml (CEPHULAC) solution  <br/>• Linzess 290 mcg capsule  <br/>• losartan (COZAAR) 50 mg tablet  <br/>• Antacid Anti-Gas 400-400-40 mg/5 mL suspension  <br/>• METOprolol succinate (TOPROL XL) 25 mg SR tablet 24 hr  <br/>• nitroGLYCERIN (NITROSTAT) 0.4 mg SL tablet  <br/>• OLANZapine (ZyPREXA) 10 mg tablet  <br/>• pantoprazole (PROTONIX) 40 mg EC DR tablet  <br/><br/>No current facility-administered medications for this visit. <br/><br/>Review of Systems:<br/>Constitutional:  No Weight Change, No Fever, No Chills, No Night Sweats, No Fatigue, No Malaise<br/>ENT/Mouth:  No Nasal Congestion, No sore throat, <br/>Eyes:  No Eye Pain, No Redness, No Discharge, No Vision Changes<br/>Cardiovascular:  No Chest Pain, No SOB, No PND, No Dyspnea on Exertion, No Orthopnea, No Claudication, No Edema, No Palpitations<br/>Respiratory:  No Cough, No Sputum, No Wheezing<br/>Gastrointestinal:  No Nausea, No Vomiting, No Diarrhea, No Constipation, No Pain, No Heartburn, No Hematochezia, No Melena<br/>Genitourinary:  No Dysuria, No Urinary Frequency, No Hematuria, No Flank Pain, No Urinary Flow Changes<br/>Musculoskeletal:  No Arthralgias, No Myalgias, No Joint Swelling, No Joint Stiffness, No Back Pain, No Neck Pain, No Injury History<br/>Skin:  No Skin Lesions, No Pruritis, No Hair Changes, No Breast/Skin Changes, No Nipple Discharge<br/>Neuro:  No Weakness, No Numbness, No Paresthesias, No Loss of Consciousness, No Syncope, No Dizziness, No Headache, No Coordination Changes, No Recent Falls<br/>Endocrine:  No Polyuria, No Polydipsia, No Temperature Intolerance<br/><br/>Objective: <br/>Vital Signs<br/>Visit Vitals<br/>BP 124/78 <br/>Pulse 65 <br/>Temp 97.1 °F (36.2 °C) <br/>Resp 17 <br/>Ht 1.753 m (5' 9") <br/>Wt 71.7 kg (158 lb) <br/>SpO2 98% <br/>BMI 23.33 kg/m² <br/><br/>Physical Examination: <br/>General : No acute distress.Well developed and nourished.<br/>HEENT:  Normocephalic and atraumatic. Pupils equal, round,  reactive to light and accomodation consensually.<br/>Neck: Supple. Trachea midline. No Jugular venous distention noted at 45 degrees, No carotid bruits.No thyromegaly. <br/>Heart: Regular rate and rythm, no murmurs, rubs or gallops. S1, S2. <br/>Lungs: Clear to auscultation bilaterally.<br/>Chest: No tenderness. <br/>Abdomen Soft, nontender. Bowel sounds are active. No hepatosplenomegaly. No abdominal bruits.<br/>Extremities: No clubbing cyanosis or edema.<br/>Neuro: Awake alert and oriented to place, time, person. No focal findings. Deep tendon reflexes WNL. <br/>Skin: No rash. Skin turgor WNL. <br/>Peripheral Pulses: equal and normal in all extremities.<br/><br/>Assessment/ Plan: <br/><br/>Patient Active Problem List <br/>Diagnosis Code <br/>• Benign hypertensive heart disease without heart failure I11.9 <br/>• Diabetes mellitus (HCC) E11.9 <br/>• Obstructive chronic bronchitis without exacerbation (HCC) J44.9 <br/>• Parkinson's disease (HCC) G20 <br/>• Chronic kidney disease (CKD) stage G3b/A1, moderately decreased glomerular filtration rate (GFR) between 30-44 mL/min/1.73 square meter and albuminuria creatinine ratio less than 30 mg/g (HCC) N18.32 <br/>• IHD (ischemic heart disease) I25.9 <br/>• Polypharmacy Z79.899 <br/><br/>Attestation: <br/>The patient was seen and examined by myself and all new and available data was reviewed in the patient’s chart.   More than 50% of the time is spent counseling the patient and family and coordinating care. <br/> <br/> <br/>MIPS (Merit-based Incentive Payment System) <br/>Applicable CPT: 99223, 99222  <br/> CHECK ALL THAT ARE MET:<br/> <br/> <br/> []?? Measure #1 (DIABETES MELLITUS): Age 18-75. Perform HbA1c at least once in current year.  No results found for: HGBA1C <br/> <br/> [x]?? Measure #5 (CHF): All ages. Prescribe ACE/ARB upon discharge for patients with left ventricular systolic dysfunction. If not, the re ason is clearly documented in the medical chart.<br/> <br/> [x]?? Measure #8 (CHF): All ages. Prescribe a beta blocker upon discharge for patients with left ventricular systolic dysfunction. If not, the reason is clearly documented in the medical chart.<br/> <br/> [x]?? Measure #47:  Advance care plan or surrogate decision maker documented in the medical record. <br/> <br/> [x]?? Measure #130(AII): Age 18+. I obtained, updated, or reviewed the patient’s current medications (including prescription, over-the-counter, herbal, nutritional supplements, and has documented it in the patient’s note.  <br/> <br/> []?? Measure #163 (DIABETES MELLITUS): Age 18-75. Perform foot exam (visual inspection and sensory exam with mono filament and a pulse exam) at least once in current year. <br/> <br/> []?? Measure #187 (Acute ischemic stroke): Age 18+.  If time last known well was less than 2 hours before time of arrival: IV thrombolytic therapy ( t-PA) initiated within three hours (&lt;= 180 minutes) of time last known well.  <br/> <br/> [x]?? Measure #318 (All): Age 65+. Screen for future fall risk at least once in current year.  HIGH risk. <br/> <br/> []?? Measure #374 (All): Send report to referring provider. <br/> <br/> []?? Measure #407(Sepsis due to MSSA bacteremia): Age 18+ Patient treated with a beta-lactam antibiotic (Nafcillin, Oxacillin or Cefazolin) as definitive therapy. <br/> <br/>For observation cases only:<br/> []?? Measure #116(acute bronchitis). Age 18-64. Do not prescribe new antibiotics on or within 3 days of episode for acute bronchitis unless separate medical reason documented<br/>  <br/> <br/>Advanced Care Planning (check option 1 or 2)<br/>1. Advanced Care Planning was offered to the patient , but the patient did not wish or was unable to provide an advanced care plan or name a surrogate decision-maker.<br/>2. V  Advanced Care Planning including voluntary discussion of advanced directives(with or without completing the relevant forms), were discussed face to face with the patient (or family member and/or surrogate) during this hospital encounter for a total of 30 minutes.<br/> <br/><br/>Patient is seeing multiple MDs.<br/><br/>Signed: Pagiel Shechter 5/24/2023 10:27 AM<br/><br/></content><br/><span class="xLabel">Electronically signed by Shechter, Pagiel, MD at 05/24/2023 10:28 AM PDT</span><br/></content></li></ul>documented in this encounter</div><h3><a name="id6" href="#toc">Plan of Treatment</a></h3><div><p>Not on file</p>documented as of this encounter</div><h3><a name="id7" href="#toc">Visit Diagnoses</a></h3><div><table><colgroup><col width="100%"/></colgroup><thead><tr><th>Diagnosis</th></tr></thead><tbody><tr ID="vdx4" class="xRowNormal"><td><p><span class="content_span">Chronic kidney disease (CKD) stage G3b/A1, moderately decreased glomerular filtration rate (GFR) between 30-44 mL/min/1.73 square meter and albuminuria creatinine ratio less than 30 mg/g (HCC)</span><span class="content_span"> - Primary</span></p></td></tr><tr ID="vdx5" class="xRowAlt"><td><p><span class="content_span">Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin (HCC)</span></p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id8" href="#toc">Care Teams</a></h3><div><table ID="ct41"><colgroup><col width="25%" span="3"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Team Member</th><th>Relationship</th><th>Specialty</th><th>Start Date</th><th>End Date</th></tr></thead><tbody><tr class="xRowNormal"><td><p>Shechter, Pagiel, MD</p><p>NPI: 1093767337</p><p>310-733-4171 (Work)</p><p>310-559-0996 (Fax)</p></td><td>PCP - General</td><td>Nephrology</td><td>8/10/21</td><td/></tr></tbody></table>documented as of this encounter</div><br/><br/></body></html>